New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma
The FDA approved acalabrutinib as a frontline option for untreated mantle cell lymphoma.
Chronic IVIG Therapy May Reduce Incidence of Cancer, Especially in Patients With CIDP
Intravenous immunoglobulin (IVIG) use over an extended period in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) was potentially associated with…
Shifting Therapeutic Urgency and TKI Strategy
An expert discusses how different tyrosine kinase inhibitor (TKI) mechanisms of action, including asciminib’s allosteric binding vs traditional ATP-competitive inhibitors,…
NCCN Guidelines and Early Response Monitoring in Chronic Myeloid Leukemia
An expert discusses how National Comprehensive Cancer Network (NCCN) guidelines recommend first-line chronic myeloid leukemia (CML) treatments including imatinib, nilotinib,…
CPKC to remedy service disruptions impacting dwell times, switches
While the railroad stated it’s “too early to offer firm predications” for a full return to service, it expects operations…
Correct Patient Misconceptions Around Biosimilars
Some patients incorrectly believe that biosimilars compromise safety or efficacy.
Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer
Psychedelic treatments may ease cancer distress at various stages of the care journey.
Walmart tests dark stores to accelerate delivery
The brick-and-mortar locations will fulfill online orders — but are not open to the public.